Lilly Gains Amyvid Approval, But Reimbursement Still A Hurdle
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly’s Avid has gained approval for its imaging agent Amyvid, a new tool in the Alzheimer’s disease diagnosis arsenal.